Eli Lilly receives marketing authorisation for baricitinib
Treatment involves adult patients with severe alopecia areata
Read More
Author: John Pinching
‘Junk’ DNA may hold the key to neurological disorders
University of Lincoln and the University of Sheffield are researching how DNA could be repaired
Read More
Santhera submits marketing authorisation application for vamorolone
The anti-inflammatory treatment is for Duchenne muscular dystrophy
Read More
LEO Pharma launches ‘AD Days Around the World’
Events will raise awareness around the impact of atopic dermatitis across cultures
Read More
Alligator Bioscience announces positive safety data from ATOR-1017 study
The research involves patients with advanced solid malignancies on tumour-directed therapy
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
